Valvular & structural heart disease

Cardiac computed tomography (CT)-scan for mitral valve calcification assessment before percutaneous commissurotomy: the multicentre prospective CALCIMIT study

Eur Heart J Cardiovasc ImagingPublished prospective multicenter study

Authors' conclusion

CT-derived MVCS provides independent, reproducible prognostic information for immediate and long-term outcomes after PMC, beyond conventional echocardiographic scores. Integrating MVCS into pre-procedural assessment may improve patient selection for PMC.

Study context

Population
Patients with rheumatic mitral stenosis undergoing non-contrast cardiac CT before percutaneous mitral commissurotomy (PMC), 2016–2019consecutive patients (mean age 56 ± 15 years, 78% women)
Participants
172 patients
Exposure
CT-based Mitral Valve Calcium Scoring (MVCS) as a predictor of immediate and long-term outcomes after PMC
Outcome
Good immediate result (GIR): final mitral valve area ≥1.5 cm² with ≥50% increase and ≤2/4 mitral regurgitation (MR)
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Good immediate result (GIR) of PMC achieved

54.7% of patients

Observational data: associations, not effects.

Secondary outcomes

Long-term survival free of mitral reintervention (secondary endpoint)

HR (95% CI)P value
MVCSIndependently associated1.54 (1.07–2.21)P = 0.019

Mitral calcification on CT

Patients with mitral calcification
113 patients (66%)

MVCS threshold

Threshold predicting both immediate and late outcomes
385.5 Agatston Units

Interobserver reproducibility

Calcification detection Kappa
0.987
MVCS correlation r
0.999

Original publication

Cardiac CT-scan for mitral valve calcification assessment before percutaneous commissurotomy: the multicentre prospective CALCIMIT study. Eur Heart J Cardiovasc Imaging. Published 23 February 2026. doi:10.1093/ehjci/jeag054

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.